tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CABA Stock Latest News

Cabaletta Bio and Cellares complete TAP for rese-cel using Cell Shuttle
The FlyCabaletta Bio and Cellares complete TAP for rese-cel using Cell Shuttle
11d ago
CABA
Promising Clinical Advances and Strategic Developments Justify Buy Rating for Cabaletta Bio
PremiumRatings
Promising Clinical Advances and Strategic Developments Justify Buy Rating for Cabaletta Bio
1M ago
CABA
Cabaletta Bio’s Promising Clinical Progress and Strong Buy Rating by Douglas Tsao
PremiumRatings
Cabaletta Bio’s Promising Clinical Progress and Strong Buy Rating by Douglas Tsao
1M ago
CABA
Cabaletta Bio Unveils Promising Clinical Data in RESET Trials
PremiumCompany Announcements
Cabaletta Bio Unveils Promising Clinical Data in RESET Trials
1M ago
8K
CABA
Cabaletta Bio’s rese-cel shows efficacy in clinical studies
PremiumThe Fly
Cabaletta Bio’s rese-cel shows efficacy in clinical studies
1M ago
CABA
Cabaletta Bio Advances Clinical Trials with Lonza Partnership
PremiumCompany AnnouncementsCabaletta Bio Advances Clinical Trials with Lonza Partnership
3M ago
8K
CABA
Cabaletta Bio announces strategic priorities, anticipated milestones for 2025
Premium
The Fly
Cabaletta Bio announces strategic priorities, anticipated milestones for 2025
3M ago
CABA
Cabaletta Bio downgraded at Evercore ISI on lack of financing clarity
Premium
The Fly
Cabaletta Bio downgraded at Evercore ISI on lack of financing clarity
3M ago
CABA
Cabaletta Bio downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Cabaletta Bio downgraded to In Line from Outperform at Evercore ISI
3M ago
CABA
Cabaletta Bio downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Cabaletta Bio downgraded to Equal Weight from Overweight at Wells Fargo
3M ago
CABA
Unusually active option classes on open December 2nd
PremiumThe Fly
Unusually active option classes on open December 2nd
4M ago
ZS
CNM
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
BBIO
CABA
Cabaletta Bio Reports Q3 2024 Financial Results
PremiumCompany AnnouncementsCabaletta Bio Reports Q3 2024 Financial Results
4M ago
CABA
Cabaletta Bio announces updated clinical data on CABA-201
Premium
The Fly
Cabaletta Bio announces updated clinical data on CABA-201
4M ago
CABA
Cabaletta Bio’s Promising Clinical Data on CABA-201
Premium
Company Announcements
Cabaletta Bio’s Promising Clinical Data on CABA-201
4M ago
8K
CABA
Cabaletta Bio price target lowered to $12 from $20 at Wells Fargo
PremiumThe Fly
Cabaletta Bio price target lowered to $12 from $20 at Wells Fargo
5M ago
CABA
Cabaletta Bio reports Q3 EPS (62c), consensus (61c)
PremiumThe Fly
Cabaletta Bio reports Q3 EPS (62c), consensus (61c)
5M ago
CABA
Cabaletta Bio sees cash runway into 1H26
PremiumThe Fly
Cabaletta Bio sees cash runway into 1H26
5M ago
CABA
3 Best Stocks to Buy Now, 10/10/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 10/10/2024, According to Top Analysts 
6M ago
WNS
CABA
Cabaletta Bio initiated with a Buy at UBS
PremiumThe FlyCabaletta Bio initiated with a Buy at UBS
6M ago
CABA
Cabaletta Bio Outlines Future Trials and Development Strategy
Premium
Company Announcements
Cabaletta Bio Outlines Future Trials and Development Strategy
6M ago
8K
CABA
Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI
Premium
The Fly
Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI
8M ago
CABA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >